Approved Symbol |
Approved Name |
Location |
Type |
No. of Association Studies (Positive/Negative/Trend)  |
Evidence[PMID] |
CHRNA6 |
cholinergic receptor, nicotinic alpha 6 |
8p22 |
Literature-origin, Mapped by Literature SNP |
1(0/1/0)
|
IEA
|
GRIN2B |
glutamate receptor, ionotropic, N-methyl D-aspartate 2B |
12p13.1 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IEA
|
GRID1 |
glutamate receptor, ionotropic, delta 1 |
10q22 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IEA
|
CHRNA3 |
cholinergic receptor, nicotinic alpha 3 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(0/1/0)
|
IEA
|
CHRNA5 |
cholinergic receptor, nicotinic alpha 5 |
15q24 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
2(1/1/0)
|
IEA
|
GRIN1 |
glutamate receptor, ionotropic, N-methyl D-aspartate 1 |
9q34.3 |
Literature-origin |
1(0/0/1)
|
ISS
|
LIN7C |
lin-7 homolog C (C. elegans) |
11p14 |
rSNP target |
0
|
IEA
|
DTNBP1 |
dystrobrevin binding protein 1 |
6p22.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
5(2/3/0)
|
IEA
|
COMT |
catechol-O-methyltransferase |
22q11.21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
21(9/12/0)
|
IEA
|
GRIN2A |
glutamate receptor, ionotropic, N-methyl D-aspartate 2A |
16p13.2 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IEA
|
ANK3 |
ankyrin 3, node of Ranvier (ankyrin G) |
10q21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
2(2/0/0)
|
IEA
|
CHRNA7 |
cholinergic receptor, nicotinic alpha 7 |
15q13.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IEA
|
GABRG3 |
gamma-aminobutyric acid (GABA) A receptor, gamma 3 |
15q12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IEA
|
CHRNA2 |
cholinergic receptor, nicotinic alpha 2 |
8p21 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
1(1/0/0)
|
IEA
|
CHRNB3 |
cholinergic receptor, nicotinic beta 3 |
8p11.21 |
Mapped by Literature SNP, Mapped by LD-proxy |
0
|
IEA
|
GABBR2 |
gamma-aminobutyric acid (GABA) B receptor, 2 |
9q22.1-q22.3 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/0/1)
|
IEA
|
ARRB1 |
arrestin, beta 1 |
11q13 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(0/1/0)
|
IEA
|
GABRA2 |
gamma-aminobutyric acid (GABA) A receptor, alpha 2 |
4p12 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
3(1/2/0)
|
IEA
|
CHRNB4 |
cholinergic receptor, nicotinic beta 4 |
15q24 |
Mapped by Literature SNP, Mapped by LD-proxy, rSNP target |
0
|
IEA
|
NLGN1 |
neuroligin 1 |
3q26.32 |
Literature-origin, Mapped by Literature SNP, Mapped by LD-proxy |
1(1/0/0)
|
IEA
|
CHRNA4 |
cholinergic receptor, nicotinic alpha 4 |
20q13.33 |
Literature-origin |
1(1/0/0)
|
IEA
|